LC-K76
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LC-K76, covering 2026-02-05 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) [EARLY_Phase 1]